Nautilus Biotechnology to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

5/27/25 8:00:00 AM ET

Biotechnology: Laboratory Analytical Instruments

Industrials

Get the next $NAUT alert in real time by email

SEATTLE, May 27, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ:NAUT, or "Nautilus")), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced the company will be participating in the Goldman Sachs 46^th Annual Global Healthcare Conference.

Nautilus' management is scheduled to participate in a fireside chat on Tuesday, June 10, 2025, at 2:00 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the "Investors" section of the company website at: www.nautilus.bio.

About Nautilus Biotechnology, Inc.

With its corporate headquarters in Seattle, Washington and its research and development headquarters in San Carlos, California, Nautilus is a development stage life sciences company working to create a platform technology for quantifying and unlocking the complexity of the proteome. Nautilus' mission is to transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. To learn more about Nautilus, visit www.nautilus.bio.

Media Contact

[email protected]

Investor Contact

[email protected]

Get the next $NAUT alert in real time by email

Date	Price Target	Rating	Analyst
12/5/2024	$1.75	Neutral → Sell	Goldman
6/27/2024	$6.00	Buy	Guggenheim
6/3/2024	$3.00	Hold	Jefferies
1/6/2022	$8.00	Equal-Weight	Morgan Stanley
11/2/2021		Outperform	Cowen & Co.
8/4/2021	$10.00	Neutral	Goldman Sachs
7/13/2021	$13.00	Buy	Jefferies

Nautilus Biotechnology to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

Chat with this insight

Recent Analyst Ratings for
$NAUT

$NAUT
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

CFO and Treasurer Mowry Anna bought $11,488 worth of shares (15,000 units at $0.77), increasing direct ownership by 22% to 83,000 units (SEC Form 4)

Chief Scientist Mallick Parag bought $9,885 worth of shares (13,500 units at $0.73), increasing direct ownership by 0.07% to 20,493,392 units (SEC Form 4)

CEO, President, and Secretary Patel Sujal M bought $76,918 worth of shares (77,233 units at $1.00), increasing direct ownership by 0.77% to 10,141,721 units (SEC Form 4)

$NAUT
Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

CFO and Treasurer Mowry Anna bought $11,488 worth of shares (15,000 units at $0.77), increasing direct ownership by 22% to 83,000 units (SEC Form 4)

Chief Scientist Mallick Parag bought $9,885 worth of shares (13,500 units at $0.73), increasing direct ownership by 0.07% to 20,493,392 units (SEC Form 4)

CEO, President, and Secretary Patel Sujal M bought $76,918 worth of shares (77,233 units at $1.00), increasing direct ownership by 0.77% to 10,141,721 units (SEC Form 4)

$NAUT
Press Releases

Fastest customizable press release news feed in the world